title: Primary malignant melanoma of the esophagus: a study of clinical features, pathology, management and prognosis.
authors.affiliation: State Key Laboratory of Oncology in South China, Department of Thoracic Surgery, Cancer Center, Sun Yat-Sen University, Guangzhou, China.
authors.forename: H
authors.initials: H
authors.lastname: Yu
authors.forename: X-Y
authors.initials: XY
authors.lastname: Huang
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: X
authors.initials: X
authors.lastname: Xie
authors.forename: J-L
authors.initials: JL
authors.lastname: Zhou
authors.forename: L-J
authors.initials: LJ
authors.lastname: Zhang
authors.forename: J-H
authors.initials: JH
authors.lastname: Fu
authors.forename: X
authors.initials: X
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003606:Dacarbazine / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D015376:Nimustine / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D015376:Nimustine; D014750:Vincristine; D003606:Dacarbazine